Sigilon Therapeutics, Inc. Human Resources Contracts & Agreements
17 Contracts & Agreements
- Bonus & Incentive Agreements (9 contracts)
- Change of Control Agreements (1)
- Compensation Agreements (2)
- Consulting Agreements (3)
- Severance Agreements (2)
- Sigilon Therapeutics, Inc. Non-Employee Director Compensation Policy, as amended on May 23, 2023 (Filed With SEC on August 7, 2023)
- Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan, as amended on May 23, 2023 (Filed With SEC on August 7, 2023)
- Sigilon Therapeutics, Inc. 2016 Equity Incentive Plan, as amended on May 23, 2023 (Filed With SEC on August 7, 2023)
- Form of Restricted Stock Unit Agreement under the Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan (Filed With SEC on March 14, 2023)
- Consulting Agreement, dated February 14, 2023, between the Company and May Orfali, M.D (Filed With SEC on March 14, 2023)
- Consulting Agreement, dated October 13, 2021, between the Company and May Orfali, M.D (Filed With SEC on March 14, 2022)
- Consulting Agreement between Sigilon Therapeutics, Inc. and Devyn Smith, dated April 26, 2021 (Filed With SEC on August 10, 2021)
- Form of Incentive Stock Option Agreement (Filed With SEC on November 30, 2020)
- Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan (Filed With SEC on November 30, 2020)
- Sigilon Therapeutics, Inc. Non-Employee Director Compensation Policy (Filed With SEC on November 13, 2020)
- Sigilon Therapeutics, Inc. 2020 Cash Incentive Plan (Filed With SEC on November 13, 2020)
- Sigilon Therapeutics, Inc. Amended and Restated Severance and Change in Control Policy (Filed With SEC on November 13, 2020)
- Form of Non-Chief Executive Officer Severance Waiver and Offer Letter Amendment (Filed With SEC on November 13, 2020)
- Severance Waiver and Offer Letter Amendment, between Sigilon Therapeutics, Inc. and Rogerio Vivaldi Coelho, M.D., dated October 26, 2020 (Filed With SEC on November 13, 2020)
- Form of Nonstatutory Stock Option Agreement under the Sigilon Therapeutics, Inc. 2016 Equity Incentive Plan (Filed With SEC on November 13, 2020)
- Form of Incentive Stock Option Agreement under the Sigilon Therapeutics, Inc. 2016 Equity Incentive Plan (Filed With SEC on November 13, 2020)
- Sigilon Therapeutics, Inc. 2016 Stock Option and Grant Equity Incentive Plan, as amended (Filed With SEC on November 13, 2020)